+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Laryngeal Cancer Therapeutics Market Report 2026 - Product Thumbnail Image

Laryngeal Cancer Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Nasopharyngeal Carcinoma Treatment Market Report 2026 - Product Thumbnail Image

Nasopharyngeal Carcinoma Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Sarcoma Drugs Market Report 2026 - Product Thumbnail Image

Sarcoma Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Neurofibroma - Pipeline Insight, 2025 - Product Thumbnail Image

Neurofibroma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Multiple Sclerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Multiple Sclerosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Gastric Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Gastric Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 550 Pages
  • Global
From
From
Bio/Pharmaceutical Outsourcing Report, May 2026 - Product Thumbnail Image

Bio/Pharmaceutical Outsourcing Report, May 2026

  • Report
  • June 2026
  • 34 Pages
  • Global
From
From
Checkpoint Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

Checkpoint Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 180 Pages
  • Global
From
From
From
Selective Estrogen Receptor Degraders - Pipeline Insight, 2025 - Product Thumbnail Image

Selective Estrogen Receptor Degraders - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Esophageal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Esophageal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 280 Pages
  • Global
From
TIGIT Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

TIGIT Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
CD (Cluster Of Differentiation) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CD (Cluster Of Differentiation) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Proto Oncogene Protein C-akt Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto Oncogene Protein C-akt Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator